MCID: MNT302
MIFTS: 29

Mental Retardation, X-Linked, Syndromic, Christianson Type

Categories: Genetic diseases, Neuronal diseases, Fetal diseases, Rare diseases, Mental diseases

Aliases & Classifications for Mental Retardation, X-Linked, Syndromic, Christianson Type

MalaCards integrated aliases for Mental Retardation, X-Linked, Syndromic, Christianson Type:

Name: Mental Retardation, X-Linked, Syndromic, Christianson Type 57 75 40 73
Mental Retardation, X-Linked Syndromic, Christianson Type 57 13
X-Linked Angelman-Like Syndrome 59 75
Mrxsch 57 75
X-Linked Intellectual Disability-Craniofacial Dysmorphism-Epilepsy-Ophthalmoplegia-Cerebellar Atrophy Syndrome 59
Mental Retardation, Microcephaly, Epilepsy, and Ataxia Syndrome 57
Mental Retardation Microcephaly Epilepsy and Ataxia Syndrome 75
X-Linked Intellectual Disability, South African Type 59
Angelman-Like Syndrome, X-Linked 57
Christianson Syndrome 59
Mrxs-Christianson 75

Characteristics:

Orphanet epidemiological data:

59
christianson syndrome
Inheritance: X-linked dominant; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal; Age of death: young Adult;

OMIM:

57
Inheritance:
x-linked dominant

Miscellaneous:
female carriers may be mildly affected
phenotypic similarities to angelman syndrome


HPO:

32
mental retardation, x-linked, syndromic, christianson type:
Inheritance x-linked dominant inheritance


Classifications:



Summaries for Mental Retardation, X-Linked, Syndromic, Christianson Type

OMIM : 57 Christianson syndrome is an X-linked neurodevelopmental and progressive mental retardation syndrome characterized by microcephaly, impaired ocular movements, severe global developmental delay, developmental regression, hypotonia, abnormal movements, and early-onset seizures of variable types. Female carriers may be mildly affected (summary by Schroer et al., 2010 and Pescosolido et al., 2014). (300243)

MalaCards based summary : Mental Retardation, X-Linked, Syndromic, Christianson Type, also known as mental retardation, x-linked syndromic, christianson type, is related to christianson syndrome, and has symptoms including ataxia, ophthalmoplegia and sleep disturbances. An important gene associated with Mental Retardation, X-Linked, Syndromic, Christianson Type is SLC9A6 (Solute Carrier Family 9 Member A6). Affiliated tissues include eye, skeletal muscle and cerebellum, and related phenotypes are microcephaly and narrow face

UniProtKB/Swiss-Prot : 75 Mental retardation, X-linked, syndromic, Christianson type: A syndrome characterized by profound mental retardation, epilepsy, ataxia, and microcephaly. It shows phenotypic overlap with Angelman syndrome.

Related Diseases for Mental Retardation, X-Linked, Syndromic, Christianson Type

Diseases related to Mental Retardation, X-Linked, Syndromic, Christianson Type via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 christianson syndrome 11.5

Symptoms & Phenotypes for Mental Retardation, X-Linked, Syndromic, Christianson Type

Symptoms via clinical synopsis from OMIM:

57
Abdomen Gastrointestinal:
dysphagia
incontinence

Head And Neck Head:
microcephaly

Head And Neck Mouth:
open mouth
drooling

Neurologic Behavioral Psychiatric Manifestations:
happy demeanor
autistic features
easily provoked laughter

Muscle Soft Tissue:
hypotonia
amyotrophy

Head And Neck Face:
long, narrow face
square, prognathic jaw
pointed jaw

Genitourinary Bladder:
incontinence

Skeletal Limbs:
contractures

Head And Neck Nose:
long, straight nose

Neurologic Central Nervous System:
sleep disturbance
truncal ataxia
cerebellar atrophy
mutism
lack of speech
more
Chest External Features:
narrow chest

Head And Neck Eyes:
ophthalmoplegia
bushy eyebrows
squint
deep, sunken eyes

Growth Other:
developmental delay

Head And Neck Ears:
large ears

Skeletal Hands:
adducted thumbs
long, thin fingers

Skin Nails Hair Hair:
bushy eyebrows

Growth Weight:
low weight (third percentile)

Skeletal Feet:
long, thin toes


Clinical features from OMIM:

300243

Human phenotypes related to Mental Retardation, X-Linked, Syndromic, Christianson Type:

59 32 (show top 50) (show all 61)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 microcephaly 59 32 Frequent (79-30%) HP:0000252
2 narrow face 59 32 Very frequent (99-80%) HP:0000275
3 long face 59 32 Very frequent (99-80%) HP:0000276
4 mandibular prognathia 59 32 Occasional (29-5%) HP:0000303
5 macrotia 59 32 Very frequent (99-80%) HP:0000400
6 strabismus 59 32 Very frequent (99-80%) HP:0000486
7 thick eyebrow 59 32 Very frequent (99-80%) HP:0000574
8 ophthalmoplegia 59 32 Frequent (79-30%) HP:0000602
9 adducted thumb 59 32 Frequent (79-30%) HP:0001181
10 cerebellar atrophy 59 32 Very frequent (99-80%) HP:0001272
11 absent speech 59 32 Very frequent (99-80%) HP:0001344
12 dysphagia 59 32 Frequent (79-30%) HP:0002015
13 truncal ataxia 59 32 Very frequent (99-80%) HP:0002078
14 mutism 59 32 Frequent (79-30%) HP:0002300
15 neuronal loss in central nervous system 59 32 Very frequent (99-80%) HP:0002529
16 abnormality of the nose 59 Occasional (29-5%)
17 deeply set eye 59 Occasional (29-5%)
18 nystagmus 59 Frequent (79-30%)
19 autism 59 Frequent (79-30%)
20 stereotypy 59 Frequent (79-30%)
21 inappropriate laughter 59 Frequent (79-30%)
22 abnormality of the thorax 59 Frequent (79-30%)
23 pectus excavatum 59 Frequent (79-30%)
24 dystonia 59 Frequent (79-30%)
25 gastroesophageal reflux 59 Frequent (79-30%)
26 gait ataxia 59 Frequent (79-30%)
27 ventriculomegaly 59 Frequent (79-30%)
28 cerebral cortical atrophy 59 Frequent (79-30%)
29 intellectual disability, profound 59 Very frequent (99-80%)
30 generalized seizures 59 Very frequent (99-80%)
31 developmental regression 59 Very frequent (99-80%)
32 arthrogryposis multiplex congenita 59 Occasional (29-5%)
33 decreased muscle mass 59 Occasional (29-5%)
34 cachexia 59 Very frequent (99-80%)
35 joint hyperflexibility 59 Occasional (29-5%)
36 aplasia/hypoplasia of the cerebellum 59 Very frequent (99-80%)
37 aplasia/hypoplasia of the corpus callosum 59 Frequent (79-30%)
38 feeding difficulties in infancy 59 Frequent (79-30%)
39 severe global developmental delay 59 Very frequent (99-80%)
40 conspicuously happy disposition 59 Frequent (79-30%)
41 death in early adulthood 59 Occasional (29-5%)
42 urinary incontinence 32 HP:0000020
43 open mouth 32 HP:0000194
44 narrow chest 32 HP:0000774
45 slender finger 32 HP:0001238
46 global developmental delay 32 HP:0001263
47 generalized hypotonia 32 HP:0001290
48 flexion contracture 32 HP:0001371
49 abnormality of the foot 32 HP:0001760
50 drooling 32 HP:0002307

UMLS symptoms related to Mental Retardation, X-Linked, Syndromic, Christianson Type:


ataxia, ophthalmoplegia, sleep disturbances, ataxia, truncal

Drugs & Therapeutics for Mental Retardation, X-Linked, Syndromic, Christianson Type

Search Clinical Trials , NIH Clinical Center for Mental Retardation, X-Linked, Syndromic, Christianson Type

Genetic Tests for Mental Retardation, X-Linked, Syndromic, Christianson Type

Anatomical Context for Mental Retardation, X-Linked, Syndromic, Christianson Type

MalaCards organs/tissues related to Mental Retardation, X-Linked, Syndromic, Christianson Type:

41
Eye, Skeletal Muscle, Cerebellum

Publications for Mental Retardation, X-Linked, Syndromic, Christianson Type

Articles related to Mental Retardation, X-Linked, Syndromic, Christianson Type:

(show all 17)
# Title Authors Year
1
Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments. ( 29772390 )
2018
2
Mixed Neurodevelopmental and Neurodegenerative Pathology in<i>Nhe6</i>-Null Mouse Model of Christianson Syndrome. ( 29349289 )
2017
3
A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome. ( 27256868 )
2016
4
A Christianson syndrome-linked deletion mutation (a88(287)ES(288)) in SLC9A6 disrupts recycling endosomal function and elicits neurodegeneration and cell death. ( 27590723 )
2016
5
X-linked Christianson syndrome: heterozygous female Slc9a6 knockout mice develop mosaic neuropathological changes and related behavioral abnormalities. ( 26515654 )
2015
6
Novel endosomal mechanisms in human axonal growth mediated by Christianson syndrome protein NHE6. ( 26531385 )
2015
7
REMOVED: Novel endosomal mechanisms in human axonal growth mediated by Christianson syndrome protein NHE6. ( 29887063 )
2015
8
Genetic and phenotypic diversity of NHE6 mutations in Christianson syndrome. ( 25044251 )
2014
9
Inaugural Christianson Syndrome Association conference: families meeting for the first time. ( 25273398 )
2014
10
A novel mutation in the endosomal Na+/H+ exchanger NHE6 (SLC9A6) causes Christianson syndrome with electrical status epilepticus during slow-wave sleep (ESES). ( 24630051 )
2014
11
Novel mutation in SLC9A6 gene in a patient with Christianson syndrome and retinitis pigmentosum. ( 22541666 )
2013
12
Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development. ( 24035762 )
2013
13
Novel SLC9A6 mutations in two families with Christianson syndrome. ( 22931061 )
2013
14
Christianson Syndrome: Spectrum of Neuroimaging Findings. ( 24285247 )
2013
15
Christianson syndrome in a patient with an interstitial Xq26.3 deletion. ( 21932316 )
2011
16
Natural history of Christianson syndrome. ( 20949524 )
2010
17
Christianson Syndrome ( 29334451 )
1993

Variations for Mental Retardation, X-Linked, Syndromic, Christianson Type

ClinVar genetic disease variations for Mental Retardation, X-Linked, Syndromic, Christianson Type:

6
(show top 50) (show all 65)
# Gene Variation Type Significance SNP ID Assembly Location
1 SLC9A6 NM_001042537.1(SLC9A6): c.860_865delAAAGTG (p.Glu287_Ser288del) deletion Pathogenic rs886037619 GRCh38 Chromosome X, 136002174: 136002179
2 SLC9A6 NM_001042537.1(SLC9A6): c.860_865delAAAGTG (p.Glu287_Ser288del) deletion Pathogenic rs886037619 GRCh37 Chromosome X, 135084333: 135084338
3 SLC9A6 NM_006359.2(SLC9A6): c.1402C> T (p.Arg468Ter) single nucleotide variant Pathogenic rs122461162 GRCh37 Chromosome X, 135106524: 135106524
4 SLC9A6 NM_006359.2(SLC9A6): c.1402C> T (p.Arg468Ter) single nucleotide variant Pathogenic rs122461162 GRCh38 Chromosome X, 136024365: 136024365
5 SLC9A6 NM_001042537.1(SLC9A6): c.603+3_603+4delAAinsCC indel Pathogenic rs730882187 GRCh37 Chromosome X, 135080347: 135080348
6 SLC9A6 NM_001042537.1(SLC9A6): c.603+3_603+4delAAinsCC indel Pathogenic rs730882187 GRCh38 Chromosome X, 135998188: 135998189
7 SLC9A6 NM_001042537.1(SLC9A6): c.608_609delAT (p.His203Leufs) deletion Pathogenic rs730882188 GRCh37 Chromosome X, 135080645: 135080646
8 SLC9A6 NM_001042537.1(SLC9A6): c.608_609delAT (p.His203Leufs) deletion Pathogenic rs730882188 GRCh38 Chromosome X, 135998486: 135998487
9 SLC9A6 NM_001042537.1(SLC9A6): c.1012_1020delGGTGCTGCT (p.Gly338_Ala340del) deletion Pathogenic rs398122849 GRCh37 Chromosome X, 135092713: 135092721
10 SLC9A6 NM_001042537.1(SLC9A6): c.1012_1020delGGTGCTGCT (p.Gly338_Ala340del) deletion Pathogenic rs398122849 GRCh38 Chromosome X, 136010554: 136010562
11 SLC9A6 NM_001042537.1(SLC9A6): c.1639G> T (p.Glu547Ter) single nucleotide variant Pathogenic rs398123003 GRCh37 Chromosome X, 135112313: 135112313
12 SLC9A6 NM_001042537.1(SLC9A6): c.1639G> T (p.Glu547Ter) single nucleotide variant Pathogenic rs398123003 GRCh38 Chromosome X, 136030154: 136030154
13 SLC9A6 NM_001042537.1(SLC9A6): c.25G> T (p.Ala9Ser) single nucleotide variant Benign rs201523857 GRCh37 Chromosome X, 135067686: 135067686
14 SLC9A6 NM_001042537.1(SLC9A6): c.25G> T (p.Ala9Ser) single nucleotide variant Benign rs201523857 GRCh38 Chromosome X, 135985527: 135985527
15 SLC9A6 NM_001042537.1(SLC9A6): c.183delG (p.Lys61Asnfs) deletion Pathogenic rs587784398 GRCh37 Chromosome X, 135067844: 135067844
16 SLC9A6 NM_001042537.1(SLC9A6): c.183delG (p.Lys61Asnfs) deletion Pathogenic rs587784398 GRCh38 Chromosome X, 135985685: 135985685
17 SLC9A6 NM_001042537.1(SLC9A6): c.367C> T (p.Pro123Ser) single nucleotide variant Uncertain significance rs587784400 GRCh37 Chromosome X, 135076986: 135076986
18 SLC9A6 NM_001042537.1(SLC9A6): c.367C> T (p.Pro123Ser) single nucleotide variant Uncertain significance rs587784400 GRCh38 Chromosome X, 135994827: 135994827
19 SLC9A6 NM_001042537.1(SLC9A6): c.412A> G (p.Ser138Gly) single nucleotide variant Uncertain significance rs587784401 GRCh37 Chromosome X, 135077031: 135077031
20 SLC9A6 NM_001042537.1(SLC9A6): c.412A> G (p.Ser138Gly) single nucleotide variant Uncertain significance rs587784401 GRCh38 Chromosome X, 135994872: 135994872
21 SLC9A6 NM_001042537.1(SLC9A6): c.685A> G (p.Ile229Val) single nucleotide variant Uncertain significance rs587784402 GRCh37 Chromosome X, 135081019: 135081019
22 SLC9A6 NM_001042537.1(SLC9A6): c.685A> G (p.Ile229Val) single nucleotide variant Uncertain significance rs587784402 GRCh38 Chromosome X, 135998860: 135998860
23 SLC9A6 NM_001042537.1(SLC9A6): c.2078T> G (p.Leu693Ter) single nucleotide variant Pathogenic rs587784399 GRCh37 Chromosome X, 135126855: 135126855
24 SLC9A6 NM_001042537.1(SLC9A6): c.2078T> G (p.Leu693Ter) single nucleotide variant Pathogenic rs587784399 GRCh38 Chromosome X, 136044696: 136044696
25 SLC9A6 NM_001042537.1(SLC9A6): c.604-1G> A single nucleotide variant Pathogenic rs797044508 GRCh37 Chromosome X, 135080640: 135080640
26 SLC9A6 NM_001042537.1(SLC9A6): c.604-1G> A single nucleotide variant Pathogenic rs797044508 GRCh38 Chromosome X, 135998481: 135998481
27 SLC9A6 NM_006359.2(SLC9A6): c.430-9_430-5delTTTTA deletion Conflicting interpretations of pathogenicity rs796053290 GRCh37 Chromosome X, 135080258: 135080262
28 SLC9A6 NM_006359.2(SLC9A6): c.430-9_430-5delTTTTA deletion Conflicting interpretations of pathogenicity rs796053290 GRCh38 Chromosome X, 135998099: 135998103
29 SLC9A6 NM_006359.2(SLC9A6): c.584+5G> A single nucleotide variant Likely pathogenic rs796053284 GRCh37 Chromosome X, 135080722: 135080722
30 SLC9A6 NM_006359.2(SLC9A6): c.584+5G> A single nucleotide variant Likely pathogenic rs796053284 GRCh38 Chromosome X, 135998563: 135998563
31 SLC9A6 NM_001042537: c.916delC undetermined variant Pathogenic
32 SLC9A6 NM_001042537.1(SLC9A6): c.882delT (p.Ala295Profs) deletion Pathogenic rs1057519394 GRCh37 Chromosome X, 135084355: 135084355
33 SLC9A6 NM_001042537.1(SLC9A6): c.882delT (p.Ala295Profs) deletion Pathogenic rs1057519394 GRCh38 Chromosome X, 136002196: 136002196
34 SLC9A6 NM_006359.2(SLC9A6): c.171C> G (p.Ile57Met) single nucleotide variant Conflicting interpretations of pathogenicity rs782296172 GRCh37 Chromosome X, 135067832: 135067832
35 SLC9A6 NM_006359.2(SLC9A6): c.171C> G (p.Ile57Met) single nucleotide variant Conflicting interpretations of pathogenicity rs782296172 GRCh38 Chromosome X, 135985673: 135985673
36 SLC9A6 NM_006359.2(SLC9A6): c.153A> G (p.Arg51=) single nucleotide variant Benign/Likely benign rs782090744 GRCh37 Chromosome X, 135067814: 135067814
37 SLC9A6 NM_006359.2(SLC9A6): c.153A> G (p.Arg51=) single nucleotide variant Benign/Likely benign rs782090744 GRCh38 Chromosome X, 135985655: 135985655
38 SLC9A6 NM_006359.2(SLC9A6): c.384T> C (p.Asn128=) single nucleotide variant Likely benign rs782529317 GRCh38 Chromosome X, 135994844: 135994844
39 SLC9A6 NM_006359.2(SLC9A6): c.384T> C (p.Asn128=) single nucleotide variant Likely benign rs782529317 GRCh37 Chromosome X, 135077003: 135077003
40 SLC9A6 NM_006359.2(SLC9A6): c.362A> G (p.His121Arg) single nucleotide variant Uncertain significance rs1060502675 GRCh37 Chromosome X, 135076981: 135076981
41 SLC9A6 NM_006359.2(SLC9A6): c.362A> G (p.His121Arg) single nucleotide variant Uncertain significance rs1060502675 GRCh38 Chromosome X, 135994822: 135994822
42 SLC9A6 NM_006359.2(SLC9A6): c.663A> G (p.Leu221=) single nucleotide variant Likely benign rs1060504685 GRCh37 Chromosome X, 135081093: 135081093
43 SLC9A6 NM_006359.2(SLC9A6): c.663A> G (p.Leu221=) single nucleotide variant Likely benign rs1060504685 GRCh38 Chromosome X, 135998934: 135998934
44 SLC9A6 NM_006359.2(SLC9A6): c.1141-8C> T single nucleotide variant Likely benign rs1060504684 GRCh37 Chromosome X, 135098796: 135098796
45 SLC9A6 NM_006359.2(SLC9A6): c.1141-8C> T single nucleotide variant Likely benign rs1060504684 GRCh38 Chromosome X, 136016637: 136016637
46 SLC9A6 NM_006359.2(SLC9A6): c.1020C> G (p.Thr340=) single nucleotide variant Likely benign rs1060504686 GRCh37 Chromosome X, 135095182: 135095182
47 SLC9A6 NM_006359.2(SLC9A6): c.1020C> G (p.Thr340=) single nucleotide variant Likely benign rs1060504686 GRCh38 Chromosome X, 136013023: 136013023
48 SLC9A6 NM_006359.2(SLC9A6): c.1668G> A (p.Pro556=) single nucleotide variant Likely benign rs1060504687 GRCh37 Chromosome X, 135122271: 135122271
49 SLC9A6 NM_006359.2(SLC9A6): c.1668G> A (p.Pro556=) single nucleotide variant Likely benign rs1060504687 GRCh38 Chromosome X, 136040112: 136040112
50 SLC9A6 NM_006359.2(SLC9A6): c.946G> A (p.Val316Met) single nucleotide variant Uncertain significance GRCh37 Chromosome X, 135095108: 135095108

Expression for Mental Retardation, X-Linked, Syndromic, Christianson Type

Search GEO for disease gene expression data for Mental Retardation, X-Linked, Syndromic, Christianson Type.

Pathways for Mental Retardation, X-Linked, Syndromic, Christianson Type

GO Terms for Mental Retardation, X-Linked, Syndromic, Christianson Type

Sources for Mental Retardation, X-Linked, Syndromic, Christianson Type

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....